A detailed history of Buck Wealth Strategies, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Buck Wealth Strategies, LLC holds 22,353 shares of EXEL stock, worth $931,002. This represents 0.13% of its overall portfolio holdings.

Number of Shares
22,353
Previous 11,964 86.84%
Holding current value
$931,002
Previous $527,000 75.14%
% of portfolio
0.13%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

BUY
$36.22 - $46.25 $376,289 - $480,491
10,389 Added 86.84%
22,353 $923,000
Q2 2025

Aug 04, 2025

BUY
$34.13 - $46.26 $169,421 - $229,634
4,964 Added 70.91%
11,964 $527,000
Q1 2025

Apr 22, 2025

SELL
$32.38 - $39.16 $48,570 - $58,739
-1,500 Reduced 17.65%
7,000 $258,000
Q3 2024

Nov 05, 2024

BUY
$21.96 - $27.6 $186,660 - $234,600
8,500 New
8,500 $220,000
Q3 2022

Oct 30, 2023

BUY
$15.68 - $22.27 $156,800 - $222,700
10,000 New
10,000 $219 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Buck Wealth Strategies, LLC Portfolio

Follow Buck Wealth Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Buck Wealth Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Buck Wealth Strategies, LLC with notifications on news.